多个州面临340B方案药房规则的法律战,法院权衡联邦与州的权力和方案遵守情况。 Multiple states face legal battles over 340B program pharmacy rules, with courts weighing federal vs. state authority and program compliance.

多个州在规范340B方案合同药房的法律方面继续面临法律挑战,罗德岛、佛蒙特州、北达科他州、俄克拉荷马州、夏威夷州、俄勒冈州、缅因州和新墨西哥州的法院审理动议、上诉和禁令请求。 Multiple states continue to face legal challenges over laws regulating 340B program contract pharmacies, with courts in Rhode Island, Vermont, North Dakota, Oklahoma, Hawaii, Oregon, Maine, and New Mexico hearing motions, appeals, and injunction requests. 联邦政府和药品制造商正在对州法规提出质疑,而法院则处理联邦监督、州权力和方案合规等问题。 The federal government and drug manufacturers are contesting state regulations, while courts address issues of federal oversight, state authority, and program compliance. 质疑政府回扣示范试点计划的案件被自愿驳回,缅因州的初步禁令请求被驳回。 A case challenging the government’s rebate model pilot program was voluntarily dismissed, and a preliminary injunction request in Maine was denied. 正在进行的诉讼反映了在340B方案的实施和执行方面持续存在的法律不确定性。 Ongoing litigation reflects persistent legal uncertainty over the 340B program’s implementation and enforcement.